Taken together, our results indicate that A2AR activation suppresses CD8+ T-cells function, at least in part, through promoting Notch1 degradation, and A2AR blockade restores Notch1, T-cell function and anti-tumor potential. The gene discussed is CD8A; the disease is neoplasm.